General practitioners (GPs) are the first point of contact for most people in Australia seeking medical attention. They play an important role in the prevention, early detection, and management of both acute and chronic diseases. In Australian general practice, antibiotics are commonly prescribed for respiratory tract infections (RTIs) despite evidence of limited efficacy [1,2]. A previous study identified that the antibiotic prescribing rates for RTIs by GPs are up to 9 times higher than recommended by practice guidelines [3]. Such findings have raised public health concerns about overprescribing antibiotics, emphasizing the need for continued monitoring of antibiotic prescribing activities in Australian general practice.

In mid-March 2020, the Australian government implemented the expansion of telehealth services covered by Medicare (Australia’s universal health insurance) in response to the COVID-19 pandemic. Subsequently, many GPs shifted care delivery from face-to-face consultations to telehealth (telephone or video-conference consultations). A study conducted in the early stage of the pandemic showed lower rates of medication prescriptions via telehealth compared to face-to-face consultations in Australian general practice [4]; however, antibiotic prescribing for RTIs by consultation modality is yet to be explored. Therefore, we examined antibiotic prescribing for RTIs via telehealth in comparison with face-to-face consultations from April 2020 to November 2021.

Between April 2020 and November 2021, a total of 105,719 individuals had an RTI diagnosis and attended 141,444 consultations: 92,318 (65.3%) face-to-face visits and 49,126 (34.7%) telehealth consultations (comprising 48,159 via telephone and 967 via video conference).

In 2020, the weekly mean antibiotic prescribing rates for RTIs were 56.7% (95% CI 54.2%-59.3%) for face-to-face consultations and 40.8% (95% CI 37.2%-44.4%) for telehealth (Figure 1). In 2021, the weekly mean prescribing rates were 58.6% (95% CI 55.8%-61.4%) for face to face and 61.0% (95% CI 59.1%-63.0%) for telehealth. We also evaluated the number of prescriptions during the study period and observed the same longitudinal trend.

At the patient level, the probability of receiving an antibiotic prescription through a telehealth consultation also increased from 59.3% (95% CI 57.6%-61.0%) in 2020 to 65.7% (95% CI 64.4%-67.0%) in 2021 (Table 1). The probability via face-to-face consultations was consistent across 2020 and 2021: 65.2% (95% CI 63.4%-66.9%) and 66.9% (95% CI 65.5%-68.2%), respectively.

Antibiotic prescribing via telehealth increased over time, with rates initially much lower than face-to-face consultations; however, the prescribing rates between the two consultation modalities became equivalent toward the end of 2021.

While telehealth offers some advantages such as less travel time and prevention of infectious disease transmissions, the caveats include limited physical examination capabilities. Such limitations may potentially impact the adequacy of medication prescribing, particularly in populations like children who have difficulty verbalizing symptoms.

Considering that high antibiotic prescribing rates for RTIs by Australian GPs is a long-standing public health concern, the findings from this study highlight the need for monitoring the impacts of telehealth on medication prescribing in general practice. Further, studies on telehealth decision-making processes for antibiotic prescribing that evaluate prescribing adequacy appear critical.